In some states* existing laws require healthcare providers (HCPs) to obtain informed consent for genetic tests. Due to changing state laws and regulations, it is the HCP’s responsibility to verify whether they practice in a state where informed consent is required prior to ordering genetic testing.
If the HCP does practice in a state where informed consent is required, there is a section on the Test Request Form (TRF) labeled Healthcare Provider’s Signature where a signature is required to begin test processing. A copy of an Informed Consent Form is available below (also included in the test kit). Please contact your Myriad Customer Service Specialist at 800-469-7423 for additional information.
Describes the benefits, risks, and limitations of genetic testing for inherited susceptibility to cancer.
Describes the benefits and limitations of Prolaris testing to determine risk for prostate cancer disease progression.
2022 Myriad, the Myriad logo, MyriadPro, the MyriadPro logo, Myriad MyRisk Hereditary Cancer, the Myriad MyRisk Hereditary Cancer logo, BRACAnalysis, the BRACAnalysis logo, Prolaris, the Prolaris logo, Foresight, the Foresight logo, GeneSight, the GeneSight logo, MyChoice, MyChoice logo, Endopredict, the Endopredict logo, Prequel, the Prequel logo are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and other jurisdictions.